Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Noriko Takeuchi is active.

Publication


Featured researches published by Noriko Takeuchi.


Mycopathologia | 2016

The First Case of Invasive Mixed-Mold Infections Due to Emericella nidulans var. echinulata and Rasamsonia piperina in a Patient with Chronic Granulomatous Disease

Naruhiko Ishiwada; Kenichi Takeshita; Takashi Yaguchi; Koo Nagasawa; Noriko Takeuchi; Haruka Hishiki; Akira Watanabe; Katsuhiko Kamei; Naoki Shimojo

A 16-year-old boy with chronic granulomatous disease presented with pneumonia and rib osteomyelitis. Emericella nidulans var. echinulata was isolated from his sputum. After starting voriconazole, Rasamsonia piperina was isolated from the rib swelling. A combination therapy of voriconazole and micafungin effectively eradicated this invasive mixed-mold infection. In immunocompromised patients, a precise pathogenic diagnosis is clinically useful for administration of an appropriate treatment regimen.


Pediatrics | 2016

Congenital Rubella Syndrome: A Case Report on Changes in Viral Load and Rubella Antibody Titers

Koo Nagasawa; Naruhiko Ishiwada; Atsushi Ogura; Tomoko Ogawa; Noriko Takeuchi; Haruka Hishiki; Naoki Shimojo

To our knowledge, this is the first report of the use of real-time reverse transcription–polymerase chain reaction to assess changes in viral load in a patient with congenital rubella syndrome (CRS). Rubella-specific antibody titers were also determined. The patient was a male neonate born to a primipara with rubella infection at 10 weeks of gestation. He had no symptoms at birth, but rubella virus was detected in his pharynx, blood, and urine. His mental and physical development was normal for 1 year; however, he was diagnosed with deafness at 13 months of age. Thus, the patient was diagnosed with CRS. Rubella infection in the pharynx was almost constant until 5 months of age; however, it increased dramatically at 6 months of age. No infection was detected at 13 months. Rubella-specific immunoglobulin M titer was consistently low until 9 months of age and then decreased gradually until it became negative at 20 months of age. Rubella-specific immunoglobulin G titer was high at birth. However, it decreased at 3 months and increased again at 4 months. This titer peaked at ∼9 months and then decreased again at 13 months. This case shows that the period after the decline in maternal antibody titers, not the neonatal period, may be the most contagious period in patients with CRS.


Journal of Infection and Chemotherapy | 2018

Mediastinal, subcutaneous and multiple muscular abscesses caused by group B streptococcus serotype VIII in a type 2 diabetes mellitus patient

Yuka Omura; Yoshiki Kusama; Noriko Takeuchi; Naruhiko Ishiwada

We report a case of mediastinal subcutaneous and multiple muscular abscesses caused by group B streptococcus serotype VIII in a type 2 diabetes mellitus patient. The patient arrived at the hospital with the chief complaint of immobility, and blood examination results suggested an acute infection and poorly controlled diabetes mellitus. Group B streptococcal bacteria were cultured from the patients blood, and identified as serotype VIII upon further analysis. The patient recovered without any sequelae after percutaneous drainage, antibiotic therapy, and intensive glycemic control. Although the incidence of group B streptococcal infection in non-pregnant adults has recently increased in many developed countries, information on serotype VIII infection is quite limited. The reason is that serotype VIII group B streptococci are a Japan-specific serotype, and rarely cause invasive infections, even in Japan. Therefore, further surveillance and case reports should be documented in the future.


Journal of Infection and Chemotherapy | 2016

Clinical and bacteriological analyses of bacteremia due to Corynebacterium striatum

Naruhiko Ishiwada; Masaharu Watanabe; Shota Murata; Noriko Takeuchi; Toshibumi Taniguchi; Hidetoshi Igari


Journal of Infection and Chemotherapy | 2017

Emergence of quinolone-resistant strains in Streptococcus pneumoniae isolated from paediatric patients since the approval of oral fluoroquinolones in Japan

Noriko Takeuchi; Misako Ohkusu; Tadashi Hoshino; Sachiko Naito; Akiko Takaya; Tomoko Yamamoto; Naruhiko Ishiwada


Journal of Infection and Chemotherapy | 2017

Analysis of Streptococcus pneumoniae and Haemophilus influenzae isolated from middle ear fluid before and after the introduction of government subsidies for pneumococcal and H. influenzae type b vaccines in Japan

Tadashi Hoshino; Noriko Takeuchi; Chie Fukasawa; Shoko Hirose; Hideyuki Okui; Hiroko Sato; Mari Sato; Yukiko Arimoto; Atsuko Nakano; Naruhiko Ishiwada


Clinical and Experimental Nephrology | 2011

Doubling of serum creatinine: is it appropriate as the endpoint for CKD? Proposal of a new surrogate endpoint based on the reciprocal of serum creatinine

Noriko Takeuchi; Emi Takenoshita; Fumino Kato; Tomoko Terajima; Makoto Ogawa; Satoshi Suzuki; Takayuki Fujii; Eriko Kobayashi; Tomoya Sakurada; Nobunori Satoh; Shiro Ueda


Medical Mycology | 2018

Nationwide survey of neonatal invasive fungal infection in Japan

Naruhiko Ishiwada; Hiroyuki Kitajima; Ichiro Morioka; Noriko Takeuchi; Mamiko Endo; Akira Watanabe; Katsuhiko Kamei


Journal of Infection and Chemotherapy | 2018

Capsular serotyping of Haemophilus influenzae by using matrix-associated laser desorption ionization-time of flight mass spectrometry

Noriko Takeuchi; Shunsuke Segawa; Naruhiko Ishiwada; Misako Ohkusu; Sachio Tsuchida; Mamoru Satoh; Kazuyuki Matsushita; Fumio Nomura


Journal of Clinical Microbiology | 2018

Clinical and Bacteriologic Analysis of Nontypeable Haemophilus influenzae Strains Isolated from Children with Invasive Diseases in Japan from 2008 to 2015

Sachiko Naito; Noriko Takeuchi; Misako Ohkusu; Azusa Takahashi-Nakaguchi; Hiroki Takahashi; Naoko Imuta; Junichiro Nishi; Mayumi Matsuoka; Yuko Sasaki; Naruhiko Ishiwada

Collaboration


Dive into the Noriko Takeuchi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tadashi Hoshino

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroko Sato

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Koo Nagasawa

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge